Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases

The mRNA-based BNT162b2 and inactivated whole-virus CoronaVac are two widely used COVID-19 vaccines that confer immune protection to healthy individuals. However, hesitancy toward COVID-19 vaccination appeared to be common for patients with neuromuscular diseases (NMDs) due to the paucity of data on...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Michael Kwan Leung Yu, Sophelia Hoi Shan Chan, Samuel Cheng, Daniel Leung, Sau Man Chan, Amy Suen Ka Yan, Wilfred Hing Sang Wong, Malik Peiris, Yu Lung Lau, Jaime S Rosa Duque
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2023-01-01
Sarja:	Human Vaccines & Immunotherapeutics
Aiheet:	bnt162b2 covid-19 coronavac neuromuscular diseases vaccine hesitancy
Linkit:	http://dx.doi.org/10.1080/21645515.2023.2206278
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!